ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ² ΠΈΠ½ΡΠ΅ΡΠΏΠΎΠ»ΠΈΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΡΠ½ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠ² Π΄Π»Ρ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ in vitro
ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π² ΡΠ°ΠΌΠΊΠ°Ρ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΠΈΠ·ΠΈΠΊΠΎ-Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ²ΠΎΠΉΡΡΠ²Π°Ρ ΠΈΠ½ΡΠ΅ΡΠΏΠΎΠ»ΠΈΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΡΠ½ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠ² ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠΎΠ»ΠΈΠΊΠ°ΡΠΈΠΎΠ½ΠΎΠ² Ρ ΠΠΠ ΠΈΠΌΠ΅ΡΡ Π±ΠΎΠ»ΡΡΠΎΠ΅ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π΄Π»Ρ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π³Π΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ². Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½ Π±ΡΡΡΡΡΠΉ ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΡΠΏΠΎΡΠΎΠ± ΡΡΠ°Π½ΡΡΠ΅ΠΊΡΠΈΠΈ ΡΡΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΊΠ°ΡΠΈΠΎΠ½Π½ΡΡ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠΎΠ². Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π½Π°… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠΈΡΠ΅Π½ΠΊΠΎΠ² Π. Π., ΠΡΠ΄ΠΊΠ΅Ρ Π. Π., ΠΠ°ΡΡΡΠΎΠ²Π° Π. Π€., ΠΠ²Π°Π½ΠΎΠ²Π° Π. Π., ΠΠΎΡ ΠΎΠ² Π‘. Π., Π‘Π°Π²ΡΠ΅Π½ΠΊΠΎ Π. Π., Π’Π΅ΠΏΠ»ΠΎΠ²Π° Π. Π. ΠΠΈΠΎΠ». ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ. 1988. -Π’. 5. — Π‘. 735−741.
- ΠΠ·ΡΠΌΡΡΠ΄ΠΎΠ² Π.Π., Π.Π. ΠΠ΅Π·ΠΈΠ½, Π.Π. ΠΠ°Π±Π°Π½ΠΎΠ². Π Π°Π²Π½ΠΎΠ²Π΅ΡΠΈΠ΅ ΠΈΠ½ΡΠ΅ΡΠΏΠΎΠ»ΠΈΡΠ»Π΅ΠΊ-ΡΡΠΎΠ»ΠΈΡΠ½ΡΡ ΡΠ΅Π°ΠΊΡΠΈΠΉ ΠΈ ΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ «ΡΠ·Π½Π°Π²Π°Π½ΠΈΡ» Π² ΡΠ°ΡΡΠ²ΠΎΡΠ°Ρ ΠΈΠ½-ΡΠ΅ΡΠΏΠΎΠ»ΠΈΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΡΠ½ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠ² // Π£ΡΠΏΠ΅Ρ ΠΈ Ρ ΠΈΠΌΠΈΠΈ. 1991. — Π’. 60. — Π‘. 1570−95.
- ΠΠ°Π±Π°Π½ΠΎΠ² Π.Π.. ΠΠΎΠ»ΠΈΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΡΠ½ΡΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΡ Π² ΡΠ°ΡΡΠ²ΠΎΡΠ΅ ΠΈ Π² ΠΊΠΎΠ½Π΄Π΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ°Π·Π΅ // Π£ΡΠΏΠ΅Ρ ΠΈ Ρ ΠΈΠΌΠΈΠΈ. 2005. — Π’. 74. — Π‘. 5−23.
- ΠΠΎΠ·ΠΌΠΎΠ³ΠΎΠ²Π° Π. Π., Π.Π. ΠΠ½ΠΎΡΡΠ΅. ΠΠ΅Π»ΠΊΠΎΠ²ΡΠ΅ ΠΈ ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΈ Π΄Π»Ρ Π΄ΠΎΡΡΠ°Π²ΠΊΠΈ Π² ΠΊΠ»Π΅ΡΠΊΡ ΠΎΠ»ΠΈΠ³ΠΎΠ½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄ΠΎΠ² ΠΈ ΠΠΠ // ΠΠΎΠΏΡΠΎΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ Ρ ΠΈΠΌΠΈΠΈ. 1999, — Π’.6.
- ΠΡΠΈΠ½Π΅Π²Π° Π.Π., ΠΠ°ΡΡΡΠΎΠ²Π° Π. Π€., ΠΠ½ΠΎΡΡΠ΅ Π. Π. ΠΠ»ΠΊΠΈΠ»ΠΈΡΡΡΡΠΈΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΠ΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ Π½ΡΠΊΠ»Π΅ΠΈΠ½ΠΎΠ²ΡΡ ΠΊΠΈΡΠ»ΠΎΡ // ΠΠ·Π²Π΅ΡΡΠΈΡ Π‘ΠΈΠ±ΠΈΡΡΠΊΠΎΠ³ΠΎ ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΡ ΠΠΊΠ°Π΄Π΅ΠΌΠΈΠΈ Π½Π°ΡΠΊ Π‘Π‘Π‘Π . Π‘Π΅Ρ. Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ Π½Π°ΡΠΊ. 1968. — Π’.12. — Π‘. 118 124.
- ΠΠ°Π±Π°Π½ΠΎΠ² Π.Π. Π€ΠΈΠ·ΠΈΠΊΠΎ-Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠ½ΠΎΠ²Ρ ΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΠ°ΡΡΠ²ΠΎΡΠΈΠΌΡΡ ΠΈΠ½ΡΠ΅ΡΠΏΠΎΠ»ΠΈΡΠ»Π΅ΠΊΡΡΠΎΠ»ΠΈΡΠ½ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠ² // ΠΡΡΠΎΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠ΅ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ. 1994. — Π’. 36(2). — Π‘. 183−197.
- Π€ΡΠΈΡΠΌΠ°Π½ Π. Π., Π¦Π²Π΅ΡΠΊΠΎΠ² Π. Π. // ΠΡΡΠ½. ΡΠΊΡΠΏ. ΠΈ ΡΠ΅ΠΎΡ. Π€ΠΈΠ·ΠΈΠΊΠΈ, 1952, Ρ. 23. Π‘. 690 702.
- Π€ΡΠΈΡΠΌΠ°Π½ Π. Π., Π‘ΠΈΠ±ΠΈΠ»Π΅Π²Π° Π. Π., ΠΡΠ°ΡΠ½ΠΎΠΏΠ΅ΡΠΎΠ²Π° Π. Π. // ΠΡΡΠΎΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠ΅ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ, 1962, Ρ. 1, Ρ. 597 -606.
- Abdallah Π., Goula D., Ghorbel Π., et al. Nonviral gene transfer for studying signaling in comparative developmental biology // Ann. N. Y. Acad. Sci. 1998.-V. 839.-P. 87−92.
- Abdallah Π., Hassan A., Benoist C., et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethilenimine // Hum. Gene Ther. 1996. — V. 7 — P. 1947−1954.
- Anderson WF. Human gene therapy // Nature. 1998 Apr. 30. -392(6679 Suppl)-P. 25−30.
- Arigita C., Zuidam N.J., Crommelin D.J., Hennink W.E. Association and dissociation characteristics of polymer/DNA complexes used for gene delivery//Pharm. Res. 1999. — V. 16, 10-P. 1534−1541.
- Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro // Proc Natl Acad Sci U S A.-1988.- V. 85.(16)-P. 6132−6.
- Baker JR Jr, Bielinska AU, Kukowska-Latallo JF. Dendrimer-mediated cell transfection in vitro // Methods Mol Biol. 2004. — V. 245. — P. 67−82.
- Basu S, Wickstrom E. Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake // Bioconjug Chem. 1997. — V. 8(4). — P. 481−8.
- Behr JP. Gene transfer with amino lipids and amino polymers // Π‘ R Seances Soc Biol Fil.- 1996. V. 190(1). — P. 33−8.
- Benihoud K., Yeh P., Perricaudet M. Adenovirus vectors for gene delivery.// Curr. Opin. Biotechnol. 1999. — V. 10(5). — P. 440−447.
- Briones J., Puig Π’., Limon A., et al. Retroviral gene transfer into human hematopoietic cells: an in vitro kinetic study // Haematologica. -1999. V. 84(6).-P. 483−488.
- Brunner S., Sauer Π’., Carotta S., et al. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus // Gene Ther. -2000.-V. 7(5).-P. 401−407.
- Bueler H. Adeno-associated viral vectors for gene transfer and gene therapy // Biol. Chem. -1999. V. 380(6). — P. 613−622.
- Carrio M., Romagosa A., Mercade E., et al. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene // Gene Ther. 1999. — V. 6(4).-P. 547−553.
- Chen J, Stickles RJ, Daichendt KA. Galactosylated histone-mediated gene transfer and expression // Hum Gene Ther.- 1994. V. 5(4). — P. 429−35.
- Cheng P.-W., Yin W. Lectin conjugate-directed gene transfer to airway epithelial cells // Biochem Biophys Res Commun. 1994. — V. 30.205 (1). -P. 826−33.
- Cho MJ, Juliano R. Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations // Trends Biotech-nol. 1996. — V. 14(5). — P. 153−8.
- Curiel DT, Wagner E, Cotten M, Birnstiel ML, Agarwal S, Li CM, Loechel S, Hu PC. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes // Hum Gene Ther. 1992. — V. 3(2). — P. 14 754.
- De Clercq E. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections // Intervirology. -1997. V. 40(5−6). -P. 295−303.
- De Clercq E. In Search of a selective antiviral chemotherapy // Clin. Microbiol. Rev. 1997. — V. 10(4). — P. 674−693.
- De Clercq, E. Synthetic interferon inducers // Top. Curr. Chem. 1974. -V. 52.-P. 173−208.
- De Garilhe M. P., De Rudder J. Effect of 2 arabinose nucleosides on the multiplication of herpes virus and vaccine in cell culture // Bull Soc Chim Biol. 1969.-V. 51(10).-P. 1521−38.
- Demeneix B, Behr JP. Polyethylenimine (PEI) // Adv Genet. 2005. -V.53. — P. 215−230.
- Demeneix B.A., Ghorbel M., Goula D. Optimizing polyethylenimine-based gene transfer into mammalian brain for analysis of promoter regulation and protein function // Methods Mol. Biol. 2000. — V. 133. — P. 2135.
- Demeneix Π., Behr J., Boussif O. Gene transfer with lipospermines and polyethylenimines // Adv. Drug. Deliv. Rev. 1998. — V. 30(1−3). — P. 8595.
- De Smedt S.C., Demeester J., Hennink W.E. Cationic polymer based gene delivery systems // Pharm. Res. 2000.- V.17(2). — P. 113−126.
- Editorial GT News // Gene Therapy. 1998, — V. 5.- P. 861−862.
- Elion G. Π., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine // Proc Natl Acad Sci USA. -1977.- V. 74(12).-P. 5716−5720.
- Ernst N, Ulrichskotter S, Schmalix WA. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant // J. Gene Med.- 1999.-V. 1(5).-P. 331−340.
- Findeis MA, Wu CH, Wu GY. Ligand-based carrier systems for delivery of DNA to hepatocytes // Methods Enzymol. 1994. — V. 247. — P. 341−51.
- Fink DJ, DeLuca NA, Yamada M, Wolfe DP, Glorioso JC. Design and application of HSV vectors for neuroprotection // Gene Ther. -2000. V. 7(2).-P. 115−9.
- Fisher KJ, Wilson JM. Biochemical and functional analysis of an adenovi-rus-based ligand complex for gene transfer // Biochem J. 1994. — V. 1.299. -P.49−58.
- Fisher KJ, Wilson JM. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer // Biochem J. -1997. V. 1.321. -P. 49−58.
- Florence Morfin and Danielle Thouvenot. Herpes simplex virus resistance to antiviral drugs // Journal of Clinical Virology.- 2003. V. 26. — P. 29−37.
- Fominaya J, Uherek C, Wels W. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor // Gene Ther. 1998. — V. 5(4). — P. 521−30.
- Fominaya J, Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system // J Biol Chem. 1996. — V. 18. — P. 10 560−8.
- Fonseca M.J., Storm G., Hennink W.E. Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy // J. Gene Med. -1999.-V. 1(6).-P. 407−414.
- Freeman S., Abboud C. N., Whartenby K. A. et al. The «bystander effect»: tumor regression when a fraction of the tumor mass is genetically modified // Cancer Res. 1993. — V. 53. — P. 5274−5283.
- Frisman E.V., Schagina L.V. Vorob’ev V.I. // Biorheology 1965.- V.2.-P.189 -194.
- Frisman, E. V., Sibileva, M. A., Krasnoperova, A. V. Hydrodynamic and optical properties of polymers in high concentration solutions. Vysokomolec. Soed. -1959. V. 1. — P. 597−606.
- Goula D., Becker N., Lemkine G.F. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes // Gene Ther. -2000. -V. 7(6).-P. 499−504.
- Guo Z., Shen J., Mital D. Efficient gene transfer and expression in islets by an adenoviral vector that lacks all viral genes // Cell Transplant. 1999. -V. 8(6).-P. 661−671.
- Haldar J, An D, de Cienfuegos L. A, Chen J, Klibanov A.M. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria // PNAS -2006.-V. 103(47)-P. 17 667−71.
- Hamre D, Brownlee Π A, Donovick R. Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones // J Immunol. -1951.-V. 67(4).-P. 305−12.
- Hatta T, Ishikawa M, Takai K, Nakada S, Yokota T, Hata T, Miura K, Takaku H. Inhibition of influenza virus RNA polymerase by 5-capped short RNA fragments // Biochem Biophys Res Commun. 1998. — V. I0. — P. 103−6.
- Howard M.K., Kershaw Π’., Gibb B. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5 // Gene Ther. 1998. — V. 5(8). — P. 1137−1147.
- Huckett B, Ariatti M, Hawtrey AO. Evidence for targeted gene transfer by receptor-mediated endocytosis. Stable expression following insulin-directed entry of NEO into HepG2 cells // Biochem Pharmacol. -1990. V. 15. — P. 253−63.
- Jones J. C., Turpin E. A., Bultmann H., Brandt C. R., and Schultz-Cherry S. Inhibition of Influenza Virus Infection by a Novel Antiviral Peptide That Targets Virai Attachment to Cells // J.Virology. 2006. — V. 80. — P. 119 601 196.
- Iida J., Nishi N., Saiki I. Macrophage activation and host augmentation against Sendai or herpes simplex virus (HSV) infections with synthetic polypeptides in mice // Int. J. Immunopharmacol. -1989. V. 11(3). — P. 249−258.
- Kay MA, Liu D, Hoogerbrugge PM. Gene therapy // Proc Natl Acad Sci USA.- 1997. V. 25. — P. 12 744−6.
- Kinchington D. Recent advances in antiviral therapy // J Clin Pathol. -1999.-V. 52(2).-P. 89−94.
- Kremer EJ, Perricaudet M. Adenovirus and adeno-associated vims mediated gene transfer // Br Med Bull. 1995. — V. 51(1). — P. 31−44.
- Kukowska-Latallo J.F., Bielinska A.U. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers // Proc. Natl. Acad. Sci. U S A. 1996. — V. 93(10). — P. 4897−4902.
- Langer J.C., Klotman M.E., Hanss Π., et al. Adeno-associated virus gene transfer into renal cells: potential for in vivo gene delivery // Exp. Nephrol.1998.-V. 6(3).-P. 189−194.
- Lee R. J, Huang L. Lipidic vector systems for gene transfer // Crit. Rev. Ther. Drug. Carrier. Syst. 1997. — V. 14(2). — P. 173−206.
- Lemkine G.F., Goula D., Becker N., et al. Optimisation of polyethylen-imine-based gene delivery to mouse brain.// J. Drug Target. 1999- 7(4): 305 312.
- Leong K.W., Mao H.Q., Truong-Le V.L., et al. DNA-polycation nano-spheres as non-viral gene delivery vehicles // J. Controlled Release. 1998. -V. 53(1−3).-P. 183−193.
- Li Y., Starr S.E., Lisziewicz J., Ho W.Z. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retro virus-mediated antitat gene transfer // Gene Ther. -2000. V. 7(4). — P. 321−328.
- Lieber A., Steinwaerder D.S., Carlson C.A., et al. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes // J. Virol.1999. V. 73(11). — P. 9314−9324.
- Lin X. Construction of new retroviral producer cells from adenoviral and retroviral vectors // Gene Ther. -1998. V. 5(9). — P. 1251−1258.
- Ma DD, Wei AQ. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes // Leuk Res. -1996.-V. 20(11−12).-P. 925−30.
- Maes R.F., Vieira A., Gomes I., et al. Potentiation of FMD vaccines with polycationic-nucleic acid complexes // Arch. Virol. -1977. V. 55(4). — P. 275−285.
- Mahato R.I. Non-viral peptide-based approaches to gene delivery 11 J. Drug Target. 1999. — V. 7(4). — P. 249−268.
- Mahato R. I., Takakura Y., Hashida M. Development of targeted delivery systems for nucleic acid drugs // J. Drug Targeting. 1997. — V.4. — P. 337 357.
- McConnaughie A.W., Spychala J., Zhao M., et al. Design and synthesis of RNA-specific groove-binding cations: implications for antiviral drug design // J. Med. Chem. 1994. — V. 37(8). — P. 1063−1069.
- Mecs I, Ganti T, Kotai A. Enhancement of interferon induction in mice by polycationic modified polypeptides // Acta Virol. -1976. V. 20(2). — P. 164−166.
- Mesnil M., Piccoli C., Tiraby G. et al. Bystander killing of cancer cells by herpes simplex vims thymidine kinase gene is mediated by connexins // Proc. natl. Acad. Sci. 124. USA. 1996. — V. 93. — P. 1831—1835.
- Miyazawa N., Leopold P.L., Hackett N.R., et al. Fiber swap between adenovirus subgroups Π and Π‘ alters intracellular trafficking of adenovirus gene transfer vectors // J. Virol. -1999. V. 73(7). — P. 6056−6065.
- Morris MC, Vidal P, Chaloin L, Heitz F, Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells // Nucleic Acids Res. 1997. — V. 15. — P. 2730−6.
- Nagahiro I., Mora B.N., Boasquevisque C.H., et al. Toxicity of cationic liposome-DNA complex in lung isograft // Transplantation. -2000. V. 69(9).-P. 1802−1805.
- Nguyen H.K., Lemieux P., Vinogradov S.V., et al. Evaluation of poly-ether-polyethyleneimine graft copolymers as gene transfer agents // Gene Ther.- 2000. V. 7(2). — P. 126−138.
- Nielsen Π Π, Egholm M. Strand displacement recognition of mixed ade-nine-cytosine sequences in double stranded DNA by thymine-guanine PNA (peptide nucleic acid) // Bioorg Med Chem. -2001. V. 9(9). — P. 2429−34.
- Palmer D.H., Chen M.J., Kerr D.J. Taking Gene Therapy into the Clinic // J Biomed Biotechnol. 2003. — V. 1. — P. 71 -77.
- Pichon C, Freulon I, Midoux P, Mayer R, Monsigny M, Roche AC. Cyto-solic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide // Antisense Nucleic Acid Drug Dev. -1997. V. 7(4). — P. 335−43.
- Pollard H, Remy JS, Loussouarn G, Demolombe S, Behr JP, Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells // J Biol Chem. 1998. — V. 27. — P. 7507−11.
- Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats // J Neurosurg. -1994. V. 81(2). -P. 256−60.
- Roizman B. The Human Herpesviruses, N.Y. 1993.
- Rose JK, Buonocore L, Whitt MA. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells // Biotechniques. -1991-V. 10(4).-P. 520−5.
- Schabel FM Jr. The antiviral activity of 9-beta-D-arabinofiiranosyladenine (ARA-A) // Chemotherapy. 1968. — V. 13(6). — P. 321−38.
- Schaeffer HJ, Beauchamp L, de Miranda P, Elion GB, Bauer DJ, Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group // Nature. -1978. V. 13. — P. 83−5.
- Schaffer D.V., Fidelman N.A., Dan N., et al. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery // Biotechnol. Bioeng. -2000. V. 67(5). — P. 598−606.
- Siddhesh D. Patil, David G. Rhodes, Diane J. Burgess. DNA-based Therapeutics and DNA Delivery Systems: A Comprehensive Review // AAPS Journal. 2005 — V. 07(01). — P. 61−77.
- Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broad-spectrum antiviral activity of Virazole: 1 -beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide // Science. 1972. — V. 25. — P. 705−6.
- Stephenson ML, Zamecnik PC. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide // Proc Natl Acad Sci U S A. 1978. — V. 75(1). — P. 285−8.
- Tamura M., Nagano Y. Modulation by polymyxin Π of the effects of interferon on human myelogenous leukemia cells // Microbiol. Immunol. -1994.-V. 38(5).-P. 407−411.
- Tomita N, Morishita R, Yamamoto K, Higaki J, Dzau VJ, Ogihara T, Kaneda Y. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes // J Gene Med. 2002. — V. 4(5). — P. 527−35.
- Touze A., Coursaget P. In vitro gene transfer using human papillomavi-rus-like particles // Nucleic Acids Res. -1998 V. 26(5). — P. 1317−1323.
- Turunen M.P., Hiltunen M.O., Ruponen M., Virkamaki L., Szoka F.C. Jr., Urtti A., Yla-Herttuala S. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes // Gene Therapy. 1999 -V. 6.-P. 6−11.
- Vile R.G. Viral mediated cell fusion: viral fusion~the making, or breaking, of a tumour// Gene Ther.- 2006. -V. 13(15).-P. 1127−30.
- Vinogradov S.V., Suzdaltseva Y.G., Kabanov A.V. Block polycationic oligonucleotide derivative: synthesis and inhibition of herpes vims reproduction // Bioconjug. Chem. 1996. — V. 7(1). — P. 3−6.
- Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells // Proc Natl Acad Sci USA. -1990. V. 87(9). — P. 3410−4.
- Wagstaff M.J., Lilley C.E., Smith J., et al. Gene transfer using a disabled herpes vims vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo // Gene Ther. -1998. V. 5(11). — P. 15 661 570.
- Wu CH, Walton CM, Wu GY. Targeted gene transfer to liver using pro-tein-DNA complexes // Methods Mol Med. 2002. — V. 69. — P. 15−23.
- Wu G. Y., Wu C.H. Receptor-mediated gene delivery and expression in vivo // J Biol. Chem. 1988. — V. 263. — P. 14 621−24.
- Wu G.Y., Wu C.H. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro // Biochemistry. -1988. V. 27. — P. 887−892.
- Wu GY, Zhan P, Sze LL, Rosenberg AR, Wu CH. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression // J Biol Chem. -1994.-V. 15.-P. 11 542−6.
- Xiao W., Chirmule N., Berta S.C., et al. Gene therapy vectors based on adeno-associated virus type 1 // J. Virol. 1999. — V. 73(5). — P. 3994−4003.
- Xu M., Chen Q.R., Kumar D., et al. In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes // Mol. Gen. & Metabolism. 1998. — V. 64. — P. 193−197.
- Xu R, Li H, Tse LY, Kung HF, Lu H, Lam KS. Diabetes gene therapy: potential and challenges // Curr Gene Ther. -2003. V. 3(1). — P. 65−82
- Yeh P., Perricaudet M. Advances in adenoviral vectors: from genetic engineering to their biology // FASEB J. 1997 — V. 11(8). — P. 615−23.
- Yin W, Cheng PW. Lectin conjugate-directed gene transfer to airway epithelial cells // Biochem Biophys Res Commun. 1994. — V. 30. — P. 82 633.
- Yla-Herttuala S., Martin J.F. Cardiovascular gene therapy // Lancet. -2000.-V. 355. -P. 213−222.
- Zallen D.T. US gene therapy in crisis. TIG, June 2000, V.16, N 6: 272 275
- Zamecnik PC, Stephenson ML. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide // Proc Natl Acad Sci USA.- 1978. V. 75(1). — P. 280−4.
- Zhou J, Wu J, Hafdi N, Behr JP, Erbacher P, Peng L. Π ΠΠΠΠ den-drimers for efficient siRNA delivery and potent gene silencing // Chem Commun (Camb). 2006. — V. 14. — P. 2362−4.